Background: MicroRNAs (miRNAs) have been shown to play a key role in regulating the
progression of cervical cancer (CC). This study aimed to develop a circulating miRNA-based …

Cervical cancer is the fourth leading cause of cancer death among women globally. The
prognosis of cervical cancer patients differs considerably, and clinical outcomes are difficult …

Growing evidence has shown that a large number of miRNAs are abnormally expressed in
cervical cancer (CC) tissues and play irreplaceable roles in tumorigenesis, progression, and …

Background: MicroRNAs (miRNAs) may act as carcinogen or tumor suppressor genes by
targeting various biological molecules. Therefore, it is important to identify significant …

Cervical cancer, a second common cancer in women, represents a major health care
problem. Papanicolaou test, colposcopy, and different types of useful biomarkers are current …

Alteration in expression of miRNAs can cause various malignant changes and the metastatic
process. Our aim was to identify the miRNAs involved in cervical squamous cell carcinoma …

OBJECTIVE: To determine the utility of plasma microRNAs (miRNAs) as biomarkers in
cervical cancer (CC). METHODS: Some studies were conducted about the specific …

Sensitive and specific biomarkers for the early detection of cervical cancer are urgently
required to reduce the high morbidity and mortality of this disease. We previously …

Background Finding new biomarkers for the early detection of cervical cancer is an essential
requirement in this field. In this study, we aimed to evaluate the expression level of potential …

Cervical cancer is one of the leading causes of cancer death in women globally, despite the
widespread use of cytology/human papillomavirus (HPV) screening. In the present study, we …